Scholarlink

Purpose <p>This study aimed to evaluate the effects of a 12-week programme, including moderate strength training with and without whole-body vibration (WBV), on chemotherapy-induced peripheral neuropathy (CIPN) associated symptoms in breast cancer patients undergoing paclitaxel-containing therapy. The goal was to assess the effects on sensory, motor, and autonomic symptoms and on balance, depth sensitivity, and the vibration sensation.</p> Methods <p>In this randomized controlled trial, 66 patients were allocated to one of three groups: (i) strength training only (SG), (ii) strength training with WBV (VG), and (iii) a control group (CG) with standard activity advices. Supervised training sessions occurred twice a week during chemotherapy. Outcomes, including balance (Fullerton Advanced Balance Scale, Berg Balance Scale), vibration sensation (tuning fork test), and CIPN symptoms (EORTC QLQ-CIPN20), were assessed at baseline (T0), 6&#xa0;weeks (T1), and 12&#xa0;weeks (T2).</p> Results <p>No adverse events were recorded, and adherence was high (68.18%). Positive trends indicated stabilized vibration sensation in the SG and VG compared to the control group, but no significant differences were observed. Vibration perception decreased less in the intervention groups, and motor symptoms worsened only in the control group. Balance remained stable across all groups.</p> Conclusion <p>Both strength training alone and combined with WBV are feasible and safe during chemotherapy. Although WBV did not provide additional benefits over strength training alone, both interventions showed potential protective effects against CIPN symptoms.</p> <p>Implications for cancer survivors.</p> <p>Moderate strength training, with or without WBV, may help prevent or alleviate CIPN symptoms, supporting better physical function during chemotherapy. Early implementation of such programmes could reduce treatment-related side effects.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Effects on chemotherapy-induced peripheral neuropathy by moderate strength training in combination with whole-body vibration in breast cancer patients

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月20日

查看全文
  • Rebecca Dalferth,
  • Hannah Hebbel,
  • Dirk Bauerschlag,
  • Anne Letsch,
  • Thorsten Schmidt

摘要

Purpose

This study aimed to evaluate the effects of a 12-week programme, including moderate strength training with and without whole-body vibration (WBV), on chemotherapy-induced peripheral neuropathy (CIPN) associated symptoms in breast cancer patients undergoing paclitaxel-containing therapy. The goal was to assess the effects on sensory, motor, and autonomic symptoms and on balance, depth sensitivity, and the vibration sensation.

Methods

In this randomized controlled trial, 66 patients were allocated to one of three groups: (i) strength training only (SG), (ii) strength training with WBV (VG), and (iii) a control group (CG) with standard activity advices. Supervised training sessions occurred twice a week during chemotherapy. Outcomes, including balance (Fullerton Advanced Balance Scale, Berg Balance Scale), vibration sensation (tuning fork test), and CIPN symptoms (EORTC QLQ-CIPN20), were assessed at baseline (T0), 6 weeks (T1), and 12 weeks (T2).

Results

No adverse events were recorded, and adherence was high (68.18%). Positive trends indicated stabilized vibration sensation in the SG and VG compared to the control group, but no significant differences were observed. Vibration perception decreased less in the intervention groups, and motor symptoms worsened only in the control group. Balance remained stable across all groups.

Conclusion

Both strength training alone and combined with WBV are feasible and safe during chemotherapy. Although WBV did not provide additional benefits over strength training alone, both interventions showed potential protective effects against CIPN symptoms.

Implications for cancer survivors.

Moderate strength training, with or without WBV, may help prevent or alleviate CIPN symptoms, supporting better physical function during chemotherapy. Early implementation of such programmes could reduce treatment-related side effects.